Open AccessIn vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer
Author(s) -
Peng Ji,
Yue Gong,
MingLiang Jin,
Huailiang Wu,
Linwei Guo,
Yu-Chen Pei,
Wen-Jun Chai,
YiZhou Jiang,
Yin Liu,
Xiao-Yan Ma,
Gen-Hong Di,
Xin Hu,
ZhiMing Shao
Publication year - 2022
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abl8247
Subject(s) - triple negative breast cancer , immune system , immunotherapy , tumor microenvironment , cancer research , crispr , in vivo , cancer immunotherapy , biology , breast cancer , immune checkpoint , cancer , immunology , transcriptome , gene , gene expression , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom